tradingkey.logo
tradingkey.logo
Search

Kazia Therapeutics Ltd

KZIA
Add to Watchlist
9.780USD
+0.180+1.88%
Close 09-23 16:00(ET)
152.07MMarket Cap
LossP/E TTM

KZIA Financials

See Kazia Therapeutics Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
152.07M
Dividend TTM
0.00
P/E TTM
-0.19
EPS TTM
-50.67
Revenue
73.76K
Net Profit
-13.40M
ROE
-3.04K%
ROA
-135.05%

Kazia Therapeutics Ltd Earnings Date

Latest Release
--
EPS / Forecast
--/--
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026H1
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
FY2020H2
FY2020H1
FY2019H2
FY2019H1
FY2018H2
FY2018H1
FY2017H2
FY2017H1
FY2016H2
FY2016H1
FY2015H2
Financial Indicators
EPS
----
---40.60
---0.67
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
456.88%105.43K
----
9958.83%1.52M
4423.25%4.21K
19961.32%15.14K
-93.60%93.10
-100.00%75.49
-93.47%1.45K
53395.92%11.71M
-0.03%22.28K
-56.20%21.89K
6.79%22.29K
22.48%49.98K
-59.54%20.87K
-48.69%40.81K
-52.18%51.58K
-54.33%79.55K
-11.16%107.87K
166.11%174.17K
2358.38%121.42K
23.92%65.45K
Net Profit
-19.12%-8.22M
----
-154.40%-11.82M
36.72%-5.76M
45.28%-4.65M
5.75%-9.10M
-435.23%-8.49M
-109.93%-9.66M
63.31%-1.59M
-14.26%-4.60M
-44.37%-4.32M
7.75%-4.03M
39.89%-3.00M
-1418.81%-4.36M
-1.94%-4.98M
110.50%330.83K
18.96%-4.89M
-13.73%-3.15M
-57.70%-6.03M
-38.83%-2.77M
5.15%-3.82M
Net Margin
----
---36466.36%
---1154.22%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
--0.79%
--2.94%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
456.88%105.43K
----
9958.83%1.52M
4423.25%4.21K
19961.32%15.14K
-93.60%93.10
-100.00%75.49
-93.47%1.45K
53395.92%11.71M
-0.03%22.28K
-56.20%21.89K
6.79%22.29K
22.48%49.98K
-59.54%20.87K
-48.69%40.81K
-52.18%51.58K
-54.33%79.55K
-11.16%107.87K
166.11%174.17K
2358.38%121.42K
23.92%65.45K
Operating profit
-41.88%-8.77M
----
-83.51%-13.00M
36.57%-5.79M
17.46%-7.08M
7.10%-9.13M
-16960.03%-8.58M
-112.42%-9.83M
101.17%50.91K
-4.39%-4.63M
-40.01%-4.35M
-6.43%-4.43M
37.97%-3.10M
33.77%-4.17M
33.21%-5.00M
4.07%-6.29M
-39.55%-7.49M
-14.55%-6.56M
-22.86%-5.37M
-57.24%-5.72M
-11.34%-4.37M
Net Profit
-19.12%-8.22M
----
-154.40%-11.82M
36.72%-5.76M
45.28%-4.65M
5.75%-9.10M
-435.23%-8.49M
-109.93%-9.66M
63.31%-1.59M
-14.26%-4.60M
-44.37%-4.32M
7.75%-4.03M
39.89%-3.00M
-1418.81%-4.36M
-1.94%-4.98M
110.50%330.83K
18.96%-4.89M
-13.73%-3.15M
-57.70%-6.03M
-38.83%-2.77M
5.15%-3.82M
Current assets
2115.41%46.69M
-61.35%2.11M
-42.95%4.10M
35.31%5.45M
10.12%7.18M
-66.77%4.03M
-70.41%6.52M
-23.38%12.13M
199.70%22.04M
198.76%15.83M
39.40%7.35M
-14.66%5.30M
-23.04%5.27M
-46.05%6.21M
-54.22%6.85M
-35.50%11.51M
-41.05%14.97M
-40.35%17.84M
-26.17%25.40M
346.47%29.92M
----
Total current liabilities
59.18%16.26M
32.34%10.22M
241.04%17.20M
102.98%7.72M
8.61%5.04M
-31.01%3.80M
4.03%4.64M
163.54%5.51M
27.62%4.46M
-3.62%2.09M
162.18%3.50M
26.86%2.17M
-53.64%1.33M
-68.92%1.71M
-30.46%2.88M
202.35%5.50M
287.91%4.14M
65.19%1.82M
-22.09%1.07M
-39.89%1.10M
----
Total assets
328.13%47.45M
-33.26%11.08M
-23.13%14.39M
-12.44%16.61M
-24.41%18.72M
-41.52%18.96M
-42.14%24.77M
6.40%32.43M
168.92%42.81M
111.77%30.48M
7.08%15.92M
-20.23%14.39M
-28.72%14.87M
-38.84%18.04M
-24.44%20.86M
-9.64%29.50M
4.31%27.60M
4.71%32.65M
-25.56%26.46M
284.39%31.18M
----
Total liabilities
22.37%16.44M
3.23%13.44M
97.11%21.07M
17.57%13.02M
-12.07%10.69M
-20.46%11.07M
-15.74%12.16M
127.98%13.92M
133.84%14.43M
5.50%6.11M
25.87%6.17M
13.57%5.79M
-25.88%4.90M
-45.76%5.10M
-18.63%6.61M
-4.31%9.40M
587.89%8.13M
709.28%9.82M
-13.73%1.18M
-33.83%1.21M
----
Total equity
1416.06%31.00M
-165.67%-2.36M
-183.14%-6.68M
-54.54%3.59M
-36.30%8.03M
-57.36%7.89M
-55.57%12.61M
-24.06%18.51M
191.12%28.38M
183.26%24.37M
-2.16%9.75M
-33.53%8.60M
-30.04%9.96M
-35.61%12.95M
-26.86%14.24M
-11.94%20.10M
-22.96%19.47M
-23.81%22.83M
-26.04%25.28M
377.33%29.97M
----
Net operating income
-12.40%-6.25M
----
50.17%-2.14M
29.91%-4.13M
47.53%-4.29M
29.20%-5.90M
-435.76%-8.18M
6.05%-8.33M
161.06%2.43M
-373.51%-8.87M
-139.95%-3.99M
40.67%-1.87M
-167.87%-1.66M
48.42%-3.16M
78.04%-620.39K
-5.73%-6.12M
14.55%-2.82M
0.32%-5.79M
1.32%-3.31M
-343.31%-5.81M
-1.59%-3.35M
Net investment
----
----
----
----
100.00%0.00
100.00%0.00
---562.53K
---1.16M
--0.00
--0.00
-100.00%0.00
--0.00
1257.52%1.67M
100.00%0.00
7117.39%122.71K
99.87%-7.15K
-107.70%-1.75K
-1241.36%-5.36M
133.99%22.70K
-10433.95%-399.41K
-238.22%-66.79K
Net financing
667.18%49.35M
----
-83.13%811.41K
-20.86%3.10M
80.37%4.81M
31986.36%3.92M
-23.11%2.67M
-99.93%12.21K
-37.12%3.47M
566.87%17.06M
--5.52M
-7.35%2.56M
--0.00
--2.76M
--0.00
100.00%0.00
-100.00%0.00
-102.36%-13.30K
-100.00%2.20
-91.02%564.64K
--31.54M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its total revenue reached 73.76K, with a year-on-year change of 1.52M.

What are the current assets of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its current assets were 3.25M, with a year-on-year change of -20.75.

What are the total assets of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its total assets of Kazia Therapeutics Ltd were 3.99M, with a year-on-year change of -72.29.

What are the total liabilities of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its total liabilities of Kazia Therapeutics Ltd were 9.45M, with a year-on-year change of -55.15.

What is the total equity of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its total equity of Kazia Therapeutics Ltd was -5.46M, with a year-on-year change of 18.21.

What is the net operating income of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its net operating income of Kazia Therapeutics Ltd was -10.31M, with a year-on-year change of 45.05.

What is the net financing of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its net financing of Kazia Therapeutics Ltd was 10.34M, with a year-on-year change of 163.63.

What is the Earnings Per Share (EPS) of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -12.22, with a year-on-year change of 99.27.

What is the net income of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its net income was -13.40M, with a year-on-year change of 23.67.

What is the net margin of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its net profit margin was -18159.65, with a year-on-year change of -1473.32.

What is the debt-to-asset ratio of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its debt-to-asset ratio was 6.53, with a year-on-year change of 122.44.

What is the Return on Assets (ROA) of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its Return on Assets (ROA) was -145.77, with a year-on-year change of -37.51.

What is the operating profit of Kazia Therapeutics Ltd?

According to Kazia Therapeutics Ltd's FY2025 earnings report, its operating profit was -10.31M, with a year-on-year change of 45.05.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.